ID
45787
Description
Principal Investigator: Wei Zheng, MD, PhD, Vanderbilt University School of Medicine, Nashville, TN, USA MeSH: Breast Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001088 The Shanghai Breast Cancer Genetics Study (SBCGS) includes data from four population-based studies conducted among Chinese women in urban Shanghai: the Shanghai Breast Cancer Study (SBCS), the Shanghai Breast Cancer Survival Study (SBCSS), the Shanghai Women's Health Study (SWHS), and the Shanghai Endometrial Cancer Study (SECS, contributing controls only). *Shanghai Breast Cancer Study (SBCS):* The SBCS is a population-based, case-control study conducted in urban Shanghai. Subject recruitment in the initial phase of the SBCS (SBCS-I) was conducted between August 1996 and March 1998. The second phase (SBCS-II) of recruitment occurred between April 2002 and February 2005. Breast cancer cases were identified through the population-based Shanghai Cancer Registry and supplemented by a rapid case-ascertainment system. Controls were randomly selected using the Shanghai Resident Registry. Approximately 3500 cases and 3500 controls were recruited in the study. *Shanghai Breast Cancer Survival Study (SBCSS) and Shanghai Endometrial Cancer Study (SECS):* The SBCSS also used the population-based Shanghai Cancer Registry to identify newly diagnosed breast cancer cases. A total of 5,046 breast cancer patients were recruited. In-person interviews were conducted to collect information on known breast cancer risk factors and anthropometrics by using protocols and questionnaires similar to those used in the SBCS. For genetic studies, controls for the SBCSS cases came from the SECS, which recruited healthy women between January 1997 and December 2003. With the exception of a few questions related specifically to breast or endometrial cancer risk, the questionnaires used in the SECS and the SBCS were very similar. *Shanghai Women's Health Study (SWHS):* The SWHS is a population-based prospective cohort study of approximately 75,000 adult women who were recruited between 1997 and 2000. The cohort has been followed by a combination of record linkage and active follow-ups. Breast cancer patients identified in the SWHS and non-cases were included in the current study.
Link
Keywords
Versions (1)
- 6/22/23 6/22/23 - Chiara Middel
Copyright Holder
Wei Zheng, MD, PhD, Vanderbilt University School of Medicine, Nashville, TN, USA
Uploaded on
June 22, 2023
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
dbGaP phs001088 Shanghai Breast Cancer Genetics Study (SBCGS)
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs, affection status of the subject for breast cancer, and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject ID, gender, breast cancer or not, and age.
- This sample attributes table contains sample ID, biological sample, analyte type, tumor status, and names of the center which conducted genotyping or sequencing.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs, affection status of the subject for breast cancer, and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject ID, gender, breast cancer or not, and age.
- This sample attributes table contains sample ID, biological sample, analyte type, tumor status, and names of the center which conducted genotyping or sequencing.
C0680251 (UMLS CUI [1,2])
C0879255 (UMLS CUI [1,2])
C2603343 (UMLS CUI [1,3])
C1706256 (UMLS CUI [1,4])
C0009932 (UMLS CUI [1,5])
C0001779 (UMLS CUI [1,6])
C0027365 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C3846158 (UMLS CUI [2,3])
C2603343 (UMLS CUI [2,4])
C1551358 (UMLS CUI [2,5])
C1706256 (UMLS CUI [2,6])
C0001779 (UMLS CUI [2,7])
C0027365 (UMLS CUI [3,1])
C0476089 (UMLS CUI [3,2])
C2603343 (UMLS CUI [3,3])
C0563116 (UMLS CUI [3,4])
C0009932 (UMLS CUI [3,5])
C0439603 (UMLS CUI [3,6])
C1708943 (UMLS CUI [3,7])
C0205394 (UMLS CUI [3,8])
C2603343 (UMLS CUI [3,9])
C1706256 (UMLS CUI [3,10])
C0027365 (UMLS CUI [4,1])
C0080339 (UMLS CUI [4,2])
C2603343 (UMLS CUI [4,3])
C0001779 (UMLS CUI [4,4])
C1442488 (UMLS CUI [4,5])
C1516879 (UMLS CUI [4,6])